• View the talks
• 36 min
  1. Streptococcus pneumoniae: serotype diversity and epidemiology

  • Dr. Bambos Charalambous
• 38 min
  2. Tuberculosis: new treatments in evolution

  • Prof. Stephen Gillespie
• 55 min
  3. Current drugs for TB treatment

  • Dr. Kasha Singh
• 41 min
  4. Global progress in TB vaccine development

  • Prof. Helen McShane
• 34 min
  5. Management of MDR and XDR TB

  • Prof. Martin Boeree
• 61 min
  6. Non-tuberculous mycobacterial pulmonary disease (NTM-PD)

  • Prof. Jakko van Ingen
• 51 min
  7. The making of an influenza pandemic

  • Prof. Jonathan Van-Tam
• 51 min
  8. Responding to pandemic influenza

  • Prof. Jonathan Van-Tam
  • Dr. Chloe Sellwood
• 38 min
  9. Controlling pandemic flu

  • Prof. John Oxford
• 30 min
  10. The future of influenza vaccines

  • Dr. Marc P. Girard
• 29 min
  11. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide

  • Dr. Marietjie Venter
  • Mrs. Orienka Hellferscee
• 34 min
  12. RSV vaccine development

  • Prof. Ruth Karron
• 32 min
  13. Respiratory mycoplasmas

  • Prof. Stephen Gillespie
• 52 min
  14. Infection in the cystic fibrosis lung

  • Dr. Stuart Elborn
• 34 min
  15. The role of infection at COPD exacerbations

  • Prof. Wisia Wedzicha
• 58 min
  16. An overview of non-cystic fibrosis bronchiectasis

  • Dr. Maeve P. Smith
• 27 min
  17. Legionella: epidemiology and human infection, environment and diagnosis

  • Dr. Diane Lindsay
• 24 min
  18. Pathogen discovery in the respiratory tract

  • Dr. H. Rogier van Doorn
• 38 min
  19. Aspergillosis infections and the lung

  • Prof. Rosemary Barnes
• 23 min
  20. Parasitic lung infections: protozoa, cestodes & trematodes

  • Dr. Vannan Kandi Vijayan
• 16 min
  21. Parasitic lung infections: nematodes

  • Dr. Vannan Kandi Vijayan
• 37 min
  22. Improving respiratory diagnostics (viruses)

  • Prof. David Murdoch

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Fungi
3. Fungal infection
4. Aspergillus species
5. Dispersion
6. Lung syndromes associated with Aspergillus
7. New syndromes
8. Overlapping syndromes
9. Invasive fungal disease in immunocompromised
10. Epidemiology of aspergillosis
11. IFD incidence in haematological malignancy
12. Invasive aspergillosis in transplant patients
13. Invasive pulmonary aspergillosis (1)
14. Invasive pulmonary aspergillosis (2)
15. Clinical diagnosis
16. Advanced invasive aspergillosis
17. Diagnosis
18. The biomarkers
19. Diagnostic tests and accuracy
20. Galactomannan
21. Galactomannan - meta analyses
22. Confounding factors
23. Beta D glucan
24. PCR
25. Defining disease
26. Host and mycological factors
27. Clinical features
28. Definitions
29. Focus on infection
30. Management strategies
31. Aspergillus treatment options
32. Additional considerations
33. Aspergillosis in ICU
34. Incidence in ICU
35. Differences between IA in ICU and in haematology
36. Other pulmonary manifestations of aspergillosis
37. Allergic bronchopulmonary aspergillosis
38. Diagnosis in CF
39. ABPA in CF
40. Treatment
41. Azole resistance
42. CPA and aspergilloma
43. Diagnostic criteria
44. Chronic aspergillosis
45. Treatment of chronic aspergillosis
46. Pathogenesis of chronic aspergillosis
47. Innate immune response to fungi
48. "Th" response
49. Genetic susceptibility
50. Mannose binding lectin
51. Dectin (1)
52. Dectin (2)
53. Conclusions

Topics Covered

• Pulmonary aspergillosis
• Invasive disease
• Clinical diagnosis
• Treatment and management strategies
• Aspergillus in the ICU
• Chronic aspergillosis

Links

Series:

• Respiratory Infection

Categories:

• Clinical Practice
• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Publication History

• Published on July 11, 2013

Financial Disclosures

• Prof. Rosemary Barnes has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.